Dr. Lucas’s research interests include pharmacology of novel anti-leukemic agents and the role of transcriptional and translational regulation in tumor cell survival and drug resistance. He joined The Ohio State University in 2000 as the director of the laboratories of Experimental Therapeutics and has been on the faculty since 2007. Dr. Lucas earned his PhD at the University of Wisconsin and completed a fellowship at the Fred Hutchinson Cancer Research Center.